- Home
- OPK vs INVA Comparison
OPK vs INVA Comparison
Compare OPK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- INVA
- Stock Information
- Founded
- OPK 2007
- INVA 1996
- Country
- OPK United States
- INVA United States
- Employees
- OPK N/A
- INVA N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- INVA Health Care
- Exchange
- OPK Nasdaq
- INVA Nasdaq
- Market Cap
- OPK 989.0M
- INVA 1.2B
- IPO Year
- OPK 1995
- INVA 2004
- Fundamental
- Price
- OPK $1.48
- INVA $18.70
- Analyst Decision
- OPK Strong Buy
- INVA Buy
- Analyst Count
- OPK 3
- INVA 1
- Target Price
- OPK $2.75
- INVA N/A
- AVG Volume (30 Days)
- OPK 2.5M
- INVA 588.9K
- Earning Date
- OPK 02-25-2025
- INVA 02-27-2025
- Dividend Yield
- OPK N/A
- INVA N/A
- EPS Growth
- OPK N/A
- INVA 46.55
- EPS
- OPK N/A
- INVA 0.99
- Revenue
- OPK $711,408,000.00
- INVA $352,745,000.00
- Revenue This Year
- OPK N/A
- INVA $16.20
- Revenue Next Year
- OPK $0.00
- INVA N/A
- P/E Ratio
- OPK N/A
- INVA $18.88
- Revenue Growth
- OPK N/A
- INVA 21.46
- 52 Week Low
- OPK $0.86
- INVA $14.33
- 52 Week High
- OPK $1.76
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- OPK 46.54
- INVA 63.20
- Support Level
- OPK $1.46
- INVA $18.19
- Resistance Level
- OPK $1.51
- INVA $18.89
- Average True Range (ATR)
- OPK 0.05
- INVA 0.30
- MACD
- OPK 0.00
- INVA 0.18
- Stochastic Oscillator
- OPK 41.67
- INVA 89.89
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.